Education

---

Undergraduate:
1978 - B.A. in Linguistics, Minor in Biology & Chemistry
Indiana University
Bloomington, Indiana

Medical:
1982 - M.D. of Osteopathic Medicine & Surgery
Oklahoma State University, College of Osteopathic Medicine
Tulsa, Oklahoma

Graduate:
1984 - Master of Public Health & Tropical Medicine
Tulane University
New Orleans, Louisiana

Internship:
1982-1983
Des Moines General Hospital
Des Moines, Iowa

Residency:
1984-1986 - Public Health & Preventive Medicine
Tulane University, School of Public Health
New Orleans, Louisiana

Residency:
1995-1997 - Internal Medicine
Philadelphia College of Osteopathic Medicine
Philadelphia, Pennsylvania

Fellowship:
1997-1999 - Nephrology
Albert Einstein Medical Center, Kraftsow Division of Nephrology
Philadelphia, Pennsylvania

Affiliated Hospitals & Clinics

---

• University Medical Center
• Ochsner Baptist Medical Center
• Ochsner Kenner Medical Center
• Touro Infirmary
• Davita Crescent City
• LSU Healthcare Network Kenner Multispecialty Clinic
• University Medical Center, LSU Renal Clinic 

---

Publications

---

1. Morse S. A Short Update on Rawang Phonology.  Linguistics of the Tibeto-Burman Area, Volume 11:2, pp. 120-132, 1988.

2. Morse S. Five Rawang Dialects Compared Plus More.  David Bradley, Eugenie, JA; Henderson & Martine Mazaudon eds, Prosodic Analysis and Asian Linguistics: to honor R.K. Sprigg. Pacific Linguistics, C-104, pp 237-250, 1988.

3. Kung, SC, Aravind B, Morse SA, Jacobs LE, Raja R. Tunneled Catheter-Associated Atrial Thrombi: Successful Treatment with Chronic Anticoagulation. Hemodialysis International. 5:32-36, 2001

4. Kung SC, Morse SA, Bloom E, Raja RM. Acid-Base Balance and Nutrition in Peritoneal Dialysis. Advances in Peritoneal Dialysis,17: 235-237, 2001.

5. Thakur V, Zhang R, Morse S, Reisin E. Obesity Hypertension: The Effects on Cardiovascular and Renal Systems. Cardiovascular Reviews and Reports. 23:213-219, 2002.

6. Zhang R, Thakur V, Morse S, Reisin E. Renal and Cardiovascular Considerations for the Nonpharmacological and Pharmacological Therapies of Obesity-Hypertension. J Hum Hypertens 16(12): 819-827, 2002.

7. Morse SA, Dang A, Thakur V, Zhang R, Reisin E. Hypertension in Chronic Dialysis Patients: pathophysiology, monitoring, and treatment.  Am J Med Sci. Apr; 325(4):194-201, 2003.

8. Morse SA, Bravo PE, Morse MC, Reisin E. The Heart in Obesity Hypertension. Expert Rev Cardiovasc Ther. Jul; 3(4): 647-658, 2005.

9. Morse SA, Zhang R, Thakur V, Reisin E. Hypertension in the Metabolic Syndrome.  Am J Med Sci.  330(6): 202-110, 2005.

10. Zhang R, Liao J, Morse S, Donelon S, Reisin E. The Kidney in the Metabolic Syndrome.  Am J Med Sci. 330(6):319-325, 2005.

11. Bravo PE, Morse S, Borne DM, Aguilar EA, Reisin E:   Leptin and Hypertension in Obesity.  Journal of Vascular Health and Risk Management 2:163-169, 2006.

12. Morse SA, Asghar A, Muntner P, Aguilar  EA, Patel D, Reisin E:   Determinants of End Stage Renal Disease in the Bogalusa Heart Study Population.  JASN 18:823A, 2007.

13. Good D, Morse SA, Ventura HO and Reisin E:  Obesity, Hypertension, and the Heart.  Review Paper.  JCMS Summer:168-172, 2008.

14. Premph O, Mendez C, Holmes W, Centatus N, Starr P, Campbell J, Williams D, Aguilar E, Asghar A, Morse S, Reisin E:  Erythro stimulating agents in sickle cell disease and end stage renal disease. Journal of Investigative Medicine 56(1):346, 2008.

15. Kathresal A, Biundo J, Blais CM, Morse S, Reisin E:  A Rare Case of Candida Arthritis in a Hemodialysis  Patient.  Am J Med Sci.  336:437-440, 2008.

Major Reports and Papers:

1. Morse S. Immunologic Aspects in Leprosy Vaccine Development.  Paper prepared for Clinical Tropical Medicine, Tulane University, New Orleans, Louisiana, 1983.

2. Morse S, Morse L.  Health Status in Three Opium Growing Lisu Villages.   Mahidol University, Thailand, 1985. 

3. Morse S, Morse L, and Adulya Viriyavejakul. Osteopathic Medicine in the USA, 1985.  Submitted to the Royal Thai Medical Society.

4. Morse S. Civil War and Opium Eradication: American Involvement in Burma. Journal of the National Democratic Front of Burma, pp 185-187, 1987.

5. Morse S. Burma:  A Briefing Book.  Kachinland Foundation.  Last version compiled1992.

6. Morse S. The development of Kachin Nationalism and the Union of Burma.  Honors Paper/Monograph in Political Science, IUPUI, April, 1992.

7. Morse S. Internal Report:  Preliminary Health Survey Trip to the Union of Burma and the Northernmost District of Putao, Project MEND, Internal Report Monographs I-IV, 1994.

8. Stephen Morse, Eric Bloom, Rasib M Raja.  Determinants of Nutrition and the Subjective Global Assessment in Peritoneal Dialysis Patients.  Primary Research Study at the Kraftsow Division of Nephrology, Albert Einstein Medical Center, Philadelphia, PA, August, 1999.  Unpublished manuscript

Research

---

Title: Occupational Medicine Research Center: lob Stress Related Hypertension
Sponsor: LOUISIANA BOARD OF REGENTS (lIEF)
Role: Co-Investigator of the Occupational Medicine Research Center
Amount: $739,310
Dates: 2000-2005

Title: Antihypertensive and lipid lowering treatment to prevent heart attack trial
Sponsor: NIH ALLHAT
Amount: $100,000
Dates: 1998-2003

Title: End Stage Renal Disease in Subjects Enrolled in the Bogalusa Heart Study: A long term community study of a rural biracial (White/Black) population
Sponsor: National Kidney Foundation-Louisiana
Role: Primary Investigator (Co-investigators: Efrain Reisin, Gerald Berenson)
Amount: $10,000
Dates: 2006-2007

Title: A prospective randomized double-blind parallel group multicenter titration study comparing the safety and efficacy of Diltiazem hydrochloride's extended release tablets taken at bedtime, to amlodipine taken in the morning in achieving optimal blood pressure control in African-American patients with Stage I and  essential hypertension
Agency: Premier Research – Omnicare
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur)
Amount: $30,108.00
Dates: 2002-2003

Title: Crossover, randomized, blinded, prospective, multicenter clinical evaluation of the rate of adverse events to FERRLECIT® in hemodialysis patients as compared to placebo and historical controls (Protocol FER9803)
Agency: Spectra Renal Research
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur)
Amount: $48,000.00
Dates: 1999-2000

Title: A randomized, double-blind, parallel group evaluation of usual care plus Cerivastatin 0.4 mg once daily compared with usual care (placebo) alone in patients with End Stage Renal Disease (ESRD) New to Hemodialysis: Cerivastatin Heart Outcomes in Renal Disease: Understanding Survival (CHORUS).
Agency: Bayer
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur)
Amount: $199,760.00
Dates: 1999-2001

Title: Prevalence of Anemia in Patients with Early Renal Insufficiency 
Agency: OrthoBiotech
Role: Co-Investigator/Coordinator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur)
Amount: $12,500
Dates: 2000

Title: Occupational Medicine Research Center: Job Stress Related Hypertension 
Agency: Louisiana Board of Regents
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur,Rubin Zhang, Grant Butterbaugh )
Amount: $739,310.00
Dates: 2000-2005

Title: Antihypertensive Efficacy of Adding Candesartan Cilexetil to Lisinopril in Comparison to Up-titration of Lisinopril: A Multi Center Trial Using ATACAND®-ZESTRIL® versus ZESTRIL® to Evaluate the Effects of Lowering Blood Pressure
Agency: AstraZeneca
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur)
Amount: $11,000
Dates: 2001-2002

Title: Nested Case Controlled Study of Potential Risk Factors for Angioedema and Angioedema-Like Events in Subjects Previously Exposed to Omapatrilat
Agency: Bristol Meyers Squibb
Role: Co-Investigator (Co-PI: Efrain Reisin, Erwin Aguilar, Vashu Thakur)
Amount: $1250
Dates: 2001

Title: A study evaluating the initiation and titration of fixed doses of novel Erythropoiesis Stimulating Protein (NESP) Therapy in subjects with chronic renal insufficiency (CRI)
Agency: AstraZeneca, AMGEN
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur, Rubin Zhang)
Amount: $15,000
Dates: 2001-2002

Title: A 6-week, Dose-comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin, Cerivastatin, Pravastatin, and Simvastatin in Subjects with Hypercholesterolemia
Agency: AstraZeneca - Parexel
Role: Co-Investigator (PI: Efrain Reisin, Co-PIs: Erwin Aguilar, Vashu Thakur, Rubin Zhang)
Dates: 2002-2003